• GUERBET : Financial agenda for 2026

    Source: Nasdaq GlobeNewswire / 19 Nov 2025 07:47:34   America/New_York

    Financial agenda for 2026

    Villepinte, November 19, 2025: Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is announcing its financial agenda for 2026.

    Publications calendar
    • 2025 ANNUAL REVENUE
    February 05, 2026, after trading
    • 2025 ANNUAL RESULTS
    March 11, 2026, after trading
    • 2026 1ST QUARTER REVENUE
    April 23, 2026, after trading
    • ANNUAL SHAREHOLDERS’ MEETING
    May 22, 2026
    • 2026 2ND QUARTER REVENUE
    July 23, 2026, after trading
    • 2026 FIRST HALF RESULTS
    September 15, 2026, after trading
    • 2026 3RD QUARTER REVENUE
    October 22, 2026, after trading

    About Guerbet

    At Guerbet, we build lasting relationships so that we enable people to live better. That is our purpose. We are a global leader in medical imaging, offering a comprehensive range of pharmaceutical products, medical devices, and digital and AI solutions for diagnostic and interventional imaging. As pioneers in contrast products for 98 years, with more than 2,905 employees worldwide, we continuously innovate and devote 9% of our revenue to Research and Development in four centers in France and the United States. Guerbet (GBT) is listed in compartment B of Euronext Paris and generated revenue of €841m in 2024. For more information, please visit www.guerbet.com.


    Contacts:

    Guerbet     
    Christine Allard, SVP Public Affairs and Corporate Communications +33 6 30 11 57 82 / christine.allard@guerbet.com

    Seitosei.Actifin                                                                                       
    Marianne Py, Financial Communication + 33 6 85 52 76 93 / marianne.py@seitosei-actifin.com
    Anne-Claire Taton, Press +33 6 02 12 25 18 / anne-claire.taton@seitosei-actifin.com

    Attachment


Share on,